Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biogen
4
×
biotech
fda
life sciences
national
national blog main
national top stories
new york top stories
novartis
4
×
san francisco top stories
boston blog main
boulder/denver blog main
boulder/denver top stories
clinical trials
detroit blog main
detroit top stories
europe top stories
indiana blog main
indiana top stories
ipo
new york blog main
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
abbvie
allergan
astrazeneca
boston top stories
cancer
deerfield management
europe blog main
gene therapy
What
bio
fda
roundup
covid
ipo
medicines
new
acquisitions
activity
announced
approvals
approved
atrophy
august
biogen
biotech
busy
ceo
clamped
collabs
daily
daniel
days
deal
decisions
delays
developing
devices
drug
drugs
economic
evrysdi
fast
friday
gilead
gilead’s
green
help
home
including
Language
unset
4
×
Current search:
biogen
×
novartis
×
unset
×
@xconomy.com
3 years ago
FDA Green-Lights Roche Spinal Muscular Atrophy Drug, First Oral Therapy
@xconomy.com
4 years ago
Bio Roundup: Fast FDA Approvals, Biogen Delays, ORIC’s IPO & More
@xconomy.com
4 years ago
Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More
@xconomy.com
4 years ago
Bio Roundup: Sarepta’s Stumble, Opioid Suits, Shkreli’s Legacy & More
